Your session is about to expire
← Back to Search
Goeckerman Therapy for Psoriasis
Study Summary
This trial looks at whether Goeckerman therapy, which combines light therapy with coal tar, is more effective than light therapy or coal tar alone in treating psoriasis.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have been diagnosed with HIV.You are being considered for light therapy or medication treatment.You have a large body surface area, more than 5%.You have a type of psoriasis that is mostly not in the form of plaques.You have psoriasis caused by medication.You have a medical condition that makes it unsafe for you to undergo phototherapy, which uses light to treat certain conditions.You have severe psoriatic arthritis that is being well controlled with your current treatment.You have immune system abnormalities caused by medication or genetics.You have had mostly moderate to severe plaque psoriasis for at least 6 months before joining the study.
- Group 1: Phototherapy Only
- Group 2: Crude Coal Tar Only
- Group 3: Goeckerman Therapy
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the participant count for this clinical trial?
"Yes, clinicaltrials.gov reports that this trial is still actively recruiting participants. Initially posted on August 1st 2018 and lastly updated March 24th 2022, the medical study requires 15 patients from a single location to be enrolled."
Are there any vacancies for enrolment in this research endeavor?
"Affirmative. According to information accessible on clinicaltrials.gov, this clinical trial has been actively searching for participants since August 1st 2018 and was last updated on March 24th 2022. As of now the study is looking for 15 subjects at one medical centre."
What medical issues does Crude Coal Tar most frequently address?
"Crude Coal Tar Only can be utilized to reduce the symptoms of dandruff, psoriasis, and dermatitis."
What possible health risks can arise from exposure to Crude Coal Tar?
"The safety of Crude Coal Tar Only was evaluated and assigned a score of 3 based on the fact that this is Phase 4 trial, which signifies its approval."
Share this study with friends
Copy Link
Messenger